|
Volumn 3, Issue 6, 2007, Pages 731-734
|
Impact of osteonecrosis of the jaw on osteoporosis management: Executive summary of an ESCEO and Foundation for Research on Osteoporosis and other Bone Diseases Working Group Meeting
|
Author keywords
Bisphosphonates; Dental surgery; Osteonecrosis of the jaw; Osteoporosis; Treatment
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CORTICOSTEROID;
IMMUNOSUPPRESSIVE AGENT;
PLACEBO;
RISEDRONIC ACID;
ZOLEDRONIC ACID;
ADJUVANT THERAPY;
ANTIANGIOGENIC ACTIVITY;
BONE BIOPSY;
BONE CANCER;
BONE DISEASE;
BONE INJURY;
BONE NECROSIS;
BONE RADIOGRAPHY;
BONE SCINTISCANNING;
BONE TURNOVER;
CLINICAL TRIAL;
COMORBIDITY;
COMPUTER ASSISTED TOMOGRAPHY;
CONFERENCE PAPER;
CONSERVATIVE TREATMENT;
DENTAL CARE;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
ELDERLY CARE;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
HYPERCALCEMIA;
JAW DISEASE;
LONG TERM EXPOSURE;
MOUTH HYGIENE;
OSTEOMYELITIS;
OSTEOPOROSIS;
PATIENT REFERRAL;
PERIODONTITIS;
POSTMENOPAUSE OSTEOPOROSIS;
RHEUMATOID ARTHRITIS;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
TOOTH EXTRACTION;
|
EID: 37549053966
PISSN: 1745509X
EISSN: 17455103
Source Type: Journal
DOI: 10.2217/1745509X.3.6.731 Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|